In-Vitro Evaluation of Antimicrobial Activities of Escherichia coli, Klebsiella pneumoniae, Salmonella typhi, Neisseria gonorrhoeae , and Candida albicans Nosodes

被引:6
|
作者
Munshi, Renuka [1 ]
Talele, Gitanjali [2 ]
Shah, Rajesh [2 ]
机构
[1] TNMC & BYL Nair Ch Hosp, Dept Clin Pharmacol, Mumbai, Maharashtra, India
[2] Life Force Fdn Trust, Res Dept, Mumbai, Maharashtra, India
关键词
antibacterial; nosodes; inhibitory concentration; potentized; in vitro; Escherichia coli; Klebsiella pneumoniae; Salmonella typhi; Neisseria gonorrhoeae; Candida albicans; HIV NOSODE;
D O I
10.1055/s-0041-1727149
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background This study presents the results of the minimum inhibitory concentration (MIC) assay of a series of nosodes: namely Escherichia coli , Klebsiella pneumoniae , Salmonella typhi , Neisseria gonorrhoeae , and Candida albicans . Each was tested against its corresponding infection as well as cross infections. Methods In-vitro efficacy of polyvalent nosodes was tested using the MIC assay technique. The nosodes, namely C. albicans polyvalent nosode (35c, 100c), N. gonorrhoeae (35c), K. pneumoniae (35c, 100c) , E. coli polyvalent nosode (35c, 100c) and Salmonella typhi polyvalent nosode (30c, 100c), were tested along with positive and negative controls. Nosodes were studied in different potencies and at 1:1 dilution. Results C. albicans polyvalent nosode 35c, 100c, N. gonorrhoeae 35c, and positive control amphotericin B showed inhibition of the growth of C. albicans species. K. pneumoniae 35c, E. coli polyvalent nosode 100c, and meropenem (positive control) showed inhibition of the growth of K. pneumoniae ; this effect was not seen with ceftriaxone, ofloxacin and amoxicillin antibiotics. E. coli polyvalent nosode 30c in 10% alcohol (direct and dilution 1:1) and the positive controls ciprofloxacin, ofloxacin, and amoxicillin showed inhibition of the growth of E. coli . The S. typhi polyvalent nosode 30c in 10% alcohol showed inhibition of growth of S. typhi . Conclusion This study reveals that the tested nosodes exhibited antibacterial potential against the corresponding micro-organisms and against other selected organisms studied using this assay.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 42 条
  • [21] Synthesis, In vitro antimicrobial activity, and In silico bioinformatical approach of xanthone-fatty acid esters against Staphylococcus aureus, Escherichia coli, and Candida albicans
    Kurniawan, Yehezkiel Steven
    Yudha, Ervan
    Jumina
    Pranowo, Harno Dwi
    Sholikhah, Eti Nurwening
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13
  • [22] The Membranotropic Peptide gH625 to Combat Mixed Candida albicans/Klebsiella pneumoniae Biofilm: Correlation between In Vitro Anti-Biofilm Activity and In Vivo Antimicrobial Protection
    Maione, Angela
    de Alteriis, Elisabetta
    Carraturo, Federica
    Galdiero, Stefania
    Falanga, Annarita
    Guida, Marco
    Di Cosmo, Anna
    Maselli, Valeria
    Galdiero, Emilia
    JOURNAL OF FUNGI, 2021, 7 (01) : 1 - 15
  • [23] FORMATION OF GERM-TUBES BY CANDIDA-ALBICANS, WHEN GROWN WITH STAPHYLOCOCCUS-PYOGENE, ESCHERICHIA-COLI, KLEBSIELLA-PNEUMONIAE, LACTOBACILIUS-ACIDOPHILUS AND PROTEUS-VULGARIS
    PUROHIT, BC
    JOSHI, KR
    RAMDEO, IN
    BHARADWAJ, TP
    MYCOPATHOLOGIA, 1977, 62 (03) : 187 - 189
  • [24] Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
    Huang, Chen
    Zheng, Beiwen
    Yu, Wei
    Niu, Tianshui
    Xiao, Tingting
    Zhang, Jing
    Xiao, Yonghong
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 103 - 112
  • [25] In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
    Urban, Carl
    Mariano, Noriel
    Rahal, James J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2732 - 2734
  • [26] In Vitro and In Vivo Activities of OP0595, a New Diazabicyclooctane, against CTX-M-15-Positive Escherichia coli and KPC-Positive Klebsiella pneumoniae
    Morinaka, Akihiro
    Tsutsumi, Yuko
    Yamada, Keiko
    Takayama, Yoshihiro
    Sakakibara, Shiro
    Takata, Toshihiko
    Abe, Takao
    Furuuchi, Takeshi
    Inamura, Seiichi
    Sakamaki, Yoshiaki
    Tsujii, Nakako
    Ida, Takashi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3001 - 3006
  • [27] Determination of the antimicrobial capacity of green tea (Camellia sinensis) against the potentially pathogenic microorganisms Escherichia coli, Salmonella enterica, Staphylococcus aureus, Listeria monocytogenes, Candida albicans and Aspergillus niger
    Mora, Andreina
    Parra, Jonathan
    Chaverri, Jose M.
    Arias, Maria Laura
    ARCHIVOS LATINOAMERICANOS DE NUTRICION, 2013, 63 (03) : 247 - 253
  • [28] Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans
    Mori, Takeshi
    Yoshida, Miyako
    Hazekawa, Mai
    Ishibashi, Daisuke
    Hatanaka, Yoshiro
    Nagao, Toshihiro
    Kakehashi, Rie
    Kojima, Honami
    Uno, Rio
    Ozeki, Minoru
    Kawasaki, Ikuo
    Yamashita, Taku
    Nishikawa, Junichi
    Uchida, Takahiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [29] Silkworm model of biofilm formation: In vivo evaluation of antimicrobial tolerance of a cross-kingdom dual-species (Escherichia coli and Candida albicans) biofilm on catheter material
    Eshima, Shintaro
    Matsumoto, Yasuhiko
    Kurakado, Sanae
    Sugita, Takashi
    PLOS ONE, 2023, 18 (07):
  • [30] Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp.
    Matuschek, E.
    Ahman, J.
    Webster, C.
    Kahlmeter, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (08) : 865 - 870